Your browser doesn't support javascript.
loading
Antagonism of the transient receptor potential melastatin­2 channel leads to targeted antitumor effects in primary human malignant melanoma cells.
McKamey, Shelby G; Jira, Lukas R; Tweed, Christopher M; Blake, Steven D; Powell, Daniel P; Daghistani, Ayah T; Koh, David W.
Afiliación
  • McKamey SG; Department of Pharmaceutical and Biomedical Sciences, Ohio Northern University, Ada, OH 45810, USA.
  • Jira LR; Department of Pharmaceutical and Biomedical Sciences, Ohio Northern University, Ada, OH 45810, USA.
  • Tweed CM; Department of Pharmaceutical and Biomedical Sciences, Ohio Northern University, Ada, OH 45810, USA.
  • Blake SD; Department of Pharmaceutical and Biomedical Sciences, Ohio Northern University, Ada, OH 45810, USA.
  • Powell DP; Department of Pharmaceutical and Biomedical Sciences, Ohio Northern University, Ada, OH 45810, USA.
  • Daghistani AT; Department of Pharmaceutical and Biomedical Sciences, Ohio Northern University, Ada, OH 45810, USA.
  • Koh DW; Department of Pharmaceutical and Biomedical Sciences, Ohio Northern University, Ada, OH 45810, USA.
Int J Oncol ; 60(4)2022 Apr.
Article en En | MEDLINE | ID: mdl-35234266
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Línea Celular Tumoral / Canales Catiónicos TRPM / Melanoma Límite: Humans Idioma: En Revista: Int J Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Línea Celular Tumoral / Canales Catiónicos TRPM / Melanoma Límite: Humans Idioma: En Revista: Int J Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos